Sep 18, 2023 / 01:00PM GMT
Operator
Ladies and gentlemen, welcome to the Advanced under Standard of Care in Hemophilia Conference Call and Live Webcast. I am Alice, the Chorus Call operator. (Operator Instructions).
At this time, it's my pleasure to hand over to Guido Oelkers, Chief Executive Officer. Please go ahead, sir.
Guido Oelkers - Swedish Orphan Biovitrum AB(publ)-CEO&President
Thank you so much, and good afternoon, respectively, good morning to this event. Let's say, it's really a great pleasure to have you all with you the sequence of events after our last event on (inaudible) very excited about it. And maybe move to the next slide, which is a forward-looking statement as per usual. Today, I'm joined by Lydia Adad who is our acting Chief Medical Officer and who will be clinical efficacy and safety of efanesoctocog alfa. I'm really delighted also to have to welcome Dr. Robert Klamroth, who is Head of Internal Medicine at the hemophilia comprehensive care center, Vivantes in Berlin, Germany. And he is not only one of the
Swedish Orphan Biovitrum AB (publ) KOL Haemophilia Call (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot